{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:19:00Z","timestamp":1792466340864,"version":"4.5.0"},"reference-count":35,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2008,7,20]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Concurrent chemoradiotherapy (CCRT) for squamous cell carcinoma of the head and neck (SCCHN) increases both local tumor control and toxicity. This study evaluates clinical factors that are associated with and might predict severe late toxicity after CCRT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients were analyzed from a subset of three previously reported Radiation Therapy Oncology Group (RTOG) trials of CCRT for locally advanced SCCHN (RTOG 91-11, 97-03, and 99-14). Severe late toxicity was defined in this secondary analysis as chronic grade 3 to 4 pharyngeal\/laryngeal toxicity (RTOG\/European Organisation for the Research and Treatment of Cancer late toxicity scoring system) and\/or requirement for a feeding tube \u2265 2 years after registration and\/or potential treatment-related death (eg, pneumonia) within 3 years. Case-control analysis was performed, with a multivariable logistic regression model that included pretreatment and treatment potential factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 230 patients were assessable for this analysis: 99 patients with severe late toxicities and 131 controls; thus, 43% of assessable patients had a severe late toxicity. On multivariable analysis, significant variables correlated with the development of severe late toxicity were older age (odds ratio 1.05 per year; P = .001); advanced T stage (odds ratio, 3.07; P = .0036); larynx\/hypopharynx primary site (odds ratio, 4.17; P = .0041); and neck dissection after CRT (odds ratio, 2.39; P = .018).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Severe late toxicity after CCRT is common. Older age, advanced T-stage, and larynx\/hypopharynx primary site were strong independent risk factors. Neck dissection after CCRT was associated with an increased risk of these complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.2007.14.8841","type":"journal-article","created":{"date-parts":[[2008,6,16]],"date-time":"2008-06-16T21:35:31Z","timestamp":1213652131000},"page":"3582-3589","source":"Crossref","is-referenced-by-count":1228,"title":["Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis"],"prefix":"10.1200","volume":"26","author":[{"given":"Mitchell","family":"Machtay","sequence":"first","affiliation":[{"name":"From the Jefferson Medical College and Kimmel Cancer Center of Thomas Jefferson University; Radiation Therapy Oncology Group Headquarters and Statistical Center and the American College of Radiology, Philadelphia, PA; Moffitt Cancer Center of University of South Florida, Tampa, FL; Departments of Radiation Oncology and Head and Neck Surgery, M.D. Anderson Cancer Center, Houston, TX; Maimonides Medical Center, NY; and Johns Hopkins University Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Moughan","sequence":"additional","affiliation":[{"name":"From the Jefferson Medical College and Kimmel Cancer Center of Thomas Jefferson University; Radiation Therapy Oncology Group Headquarters and Statistical Center and the American College of Radiology, Philadelphia, PA; Moffitt Cancer Center of University of South Florida, Tampa, FL; Departments of Radiation Oncology and Head and Neck Surgery, M.D. Anderson Cancer Center, Houston, TX; Maimonides Medical Center, NY; and Johns Hopkins University Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Trotti","sequence":"additional","affiliation":[{"name":"From the Jefferson Medical College and Kimmel Cancer Center of Thomas Jefferson University; Radiation Therapy Oncology Group Headquarters and Statistical Center and the American College of Radiology, Philadelphia, PA; Moffitt Cancer Center of University of South Florida, Tampa, FL; Departments of Radiation Oncology and Head and Neck Surgery, M.D. Anderson Cancer Center, Houston, TX; Maimonides Medical Center, NY; and Johns Hopkins University Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Garden","sequence":"additional","affiliation":[{"name":"From the Jefferson Medical College and Kimmel Cancer Center of Thomas Jefferson University; Radiation Therapy Oncology Group Headquarters and Statistical Center and the American College of Radiology, Philadelphia, PA; Moffitt Cancer Center of University of South Florida, Tampa, FL; Departments of Radiation Oncology and Head and Neck Surgery, M.D. Anderson Cancer Center, Houston, TX; Maimonides Medical Center, NY; and Johns Hopkins University Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal S.","family":"Weber","sequence":"additional","affiliation":[{"name":"From the Jefferson Medical College and Kimmel Cancer Center of Thomas Jefferson University; Radiation Therapy Oncology Group Headquarters and Statistical Center and the American College of Radiology, Philadelphia, PA; Moffitt Cancer Center of University of South Florida, Tampa, FL; Departments of Radiation Oncology and Head and Neck Surgery, M.D. Anderson Cancer Center, Houston, TX; Maimonides Medical Center, NY; and Johns Hopkins University Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S.","family":"Cooper","sequence":"additional","affiliation":[{"name":"From the Jefferson Medical College and Kimmel Cancer Center of Thomas Jefferson University; Radiation Therapy Oncology Group Headquarters and Statistical Center and the American College of Radiology, Philadelphia, PA; Moffitt Cancer Center of University of South Florida, Tampa, FL; Departments of Radiation Oncology and Head and Neck Surgery, M.D. Anderson Cancer Center, Houston, TX; Maimonides Medical Center, NY; and Johns Hopkins University Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Forastiere","sequence":"additional","affiliation":[{"name":"From the Jefferson Medical College and Kimmel Cancer Center of Thomas Jefferson University; Radiation Therapy Oncology Group Headquarters and Statistical Center and the American College of Radiology, Philadelphia, PA; Moffitt Cancer Center of University of South Florida, Tampa, FL; Departments of Radiation Oncology and Head and Neck Surgery, M.D. Anderson Cancer Center, Houston, TX; Maimonides Medical Center, NY; and Johns Hopkins University Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Kian","family":"Ang","sequence":"additional","affiliation":[{"name":"From the Jefferson Medical College and Kimmel Cancer Center of Thomas Jefferson University; Radiation Therapy Oncology Group Headquarters and Statistical Center and the American College of Radiology, Philadelphia, PA; Moffitt Cancer Center of University of South Florida, Tampa, FL; Departments of Radiation Oncology and Head and Neck Surgery, M.D. Anderson Cancer Center, Houston, TX; Maimonides Medical Center, NY; and Johns Hopkins University Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e3280f01010"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)90011-4"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Brizel DM, Albers MA, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 328:1798,1998-1804,","DOI":"10.1056\/NEJM199806183382503"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.4.1318"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.24.2081"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<876::AID-CNCR19>3.0.CO;2-Y"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)03792-6"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(01)01544-9"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.010"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.09.041"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(05)80064-0"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(02)00404-8"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1007\/s004320000215"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031317"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.12.012"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.12.060"},{"key":"R17","unstructured":"Garden AS, Pajak T, Vokes E, et al: Preliminary results of RTOG 9703: A phase II randomized trial of concurrent radiation (RT) and chemotherapy for advanced squamous cell carcinomas (SCC) of the head and neck. Proc Am Soc Clin Oncol 20:223a,2001,  (abstr 891)"},{"key":"R18","unstructured":"Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data . New York, NY, John Wiley & Sons, pp 167,1980-169"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176350951"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00262-W"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Lango M, Ende K, Ahmad S, et al: Neck dissection following organ preservation protocols prolongs feeding tube dependence in patients with advanced head and neck cancer. J Clin Oncol 24:286s,2006,  (suppl; abstr 5525)","DOI":"10.1200\/jco.2006.24.18_suppl.5525"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.01.047"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.05.050"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.021"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.10.039"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2005.10.054"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.2.117"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.02.049"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-6-738"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Ning S, Shuii C, Khan WB, et al: Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo. Int J Radiat Oncol Biol Phys 40:177,1997-187,","DOI":"10.1016\/S0360-3016(97)00561-0"},{"key":"R31","unstructured":"Greenberger JS, Epperly MW: Review: Antioxidant gene therapeutic approaches to normal tissue radioprotection and tumor radiosensitization. In Vivo 21:141,2007-146,"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(03)01454-8"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.0079"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Ang KK, Pajak T, Rosenthal D, et al: A phase III trial to compare standard versus accelerated fractionation in combination with concurrent cisplatin for head and neck carcinomas (RTOG 0129): Report of compliance and toxicity. Int J Radiat Oncol Biol Phys 69: 2008 (suppl; abstr 21)","DOI":"10.1016\/j.ijrobp.2007.07.023"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.4.877"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2007.14.8841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T16:25:21Z","timestamp":1653495921000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2007.14.8841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,20]]},"references-count":35,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2008,7,20]]}},"alternative-id":["10.1200\/JCO.2007.14.8841"],"URL":"https:\/\/doi.org\/10.1200\/jco.2007.14.8841","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1120343.576515","asserted-by":"object"}]},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,20]]}}}